Skip to main content
. 2026 Jun 24;18(13):2042. doi: 10.3390/cancers18132042
ESR-1 Estrogen receptor-1
ORR Overall response rate
PFS Progression-free survival
TTNT Median time to next treatment
OS Overall survival